BioSpace News Archive

TC BioPharm (Holdings) PLC (“TC BioPharm” or the “Company”) (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer, today announced that it will be presenting virtually at the upcoming H.C. Wainwright event from Monday, September 11th through Wednesday, September 13th starting at 7:00 a.m. ET.

Amit Zeisel, PhD and Ido Solt, MD and their research team at the Technion – Israel Institute of Technology and Rambam Hospital, together with Prof. Simcha Yagel, MD of Hadassa Hospital, have published new research that provides systematic molecular evidence for two disease pathways for preeclampsia, a life-threatening hypertensive disorder of pregnancy.

TwinStrand Biosciences®, the pioneer in Duplex Sequencing technology, which delivers accurate insights to researchers in applications ranging from residual cancer detection to genetic toxicology announced the appointment of Ron Andrews, as Chief Executive Officer and Board Member.

Akadeum Life Sciences, the global leaders in buoyancy-based cell separation technology, have today announced the release of their ‘Human T Cell Activation & Expansion Kit’ with Buoyancy Activated Cell Sorting (BACS) microbubbles.

Alpenglow Biosciences (Alpenglow), creators of an innovative end-to-end 3D spatial biology platform and suite of quantitative spatial statistical analysis tools, revealed their first annual 3D Spatial Summit scheduled for September 21, 2023 in Cambridge, Massachusetts.

Applied DNA Sciences, Inc. (NASDAQ:APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today announced the general availability of Linea™ IVT platform evaluation kits (the “Kit”) and the first shipment of a Kit to an existing Linea™ IVT Template customer.

Radiaction Medical, LTD, a medical device company whose mission is to provide radiation protection to the entire medical staff during interventional procedures, made two announcements.

Marrow Access Technologies announced today that it signed a distribution agreement with Spartan Medical.

The Lung Cancer Research Foundation is pleased to announce the appointment of a select group of volunteers as its Research Advocates.

Co-Diagnostics, Inc. (Nasdaq: CODX) (“Co-Dx™" or the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it is pleased to welcome Ivory Chang as the Company’s Chief Regulatory Affairs Officer.